Đang chuẩn bị liên kết để tải về tài liệu:
Health and Quality of Life Outcomes BioMed Central Research Open Access Quality of life of men

Health and Quality of Life Outcomes BioMed Central Research Open Access Quality of life of men treated with brachytherapies for prostate cancer Elise L Lev*1, Lucille Sanzero Eller1, Glen Gejerman2, Patricia Lane2, Steven V Owen3, Michele White1 and Njoki Nganga1 Address: 1College of Nursing, Rutgers, The State University of New Jersey, Newark, NJ 07102, USA, 2Prostate Cancer Institute of New Jersey, Hackensack University Medical Center, Hackensack, NJ 07601, USA and 3Center for Epidemiology & Biostatistics, University of Texas Health Science Center at San Antonio, San Antonio, TX, 78229-3900, USA Email: Elise L Lev* - eliselev@andromeda.rutgers.edu; Lucille Sanzero Eller - eller@nightingale.rutgers.edu; Glen Gejerman - ggejerman@humed.com; Patricia Lane. | BioMed Central Health and Quality of Life Outcomes Research Open Access Quality of life of men treated with brachytherapies for prostate cancer Elise L Lev 1 Lucille Sanzero Eller1 Glen Gejerman2 Patricia Lane2 Steven V Owen3 Michele White1 and Njoki Nganga1 Address 1College of Nursing Rutgers The State University of New Jersey Newark NJ 07102 USA 2Prostate Cancer Institute of New Jersey Hackensack University Medical Center Hackensack NJ 07601 USA and 3Center for Epidemiology Biostatistics University of Texas Health Science Center at San Antonio San Antonio TX 78229-3900 USA Email Elise L Lev - eliselev@andromeda.rutgers.edu Lucille Sanzero Eller - eller@nightingale.rutgers.edu Glen Gejerman - ggejerman@humed.com Patricia Lane - plane@humed.com Steven V Owen - OwenSV@uthscsa.edu Michele White - ewhite3142@aol.com Njoki Nganga - njokinganga@hotmail.com Corresponding author Published 15 June 2004 Received 04 April 2004 Accepted 15 June 2004 Health and Quality of Life Outcomes 2004 2 28 This article is available from http www.hqlo.cOm content 2 1 28 2004 Lev et al licensee BioMed Central Ltd. This is an Open Access article verbatim copying and redistribution of this article are permitted in all media for any purpose provided this notice is preserved along with the article s original URL. Abstract Background Most studies of men undergoing treatment for prostate cancer examine physical symptoms as predictors of Quality of Life QOL . However symptoms vary by treatment modality in this population and psychosocial variables shown to be important to QOL have rarely been examined. Litwin noted a need for analysis of QOL data in men treated for prostate cancer with different modes of therapy as studies focusing on specific treatments will increase the homogeneity of research findings. Methods This cross-sectional study explored physical and psychosocial predictors of QOL in men receiving one of two types of radiation treatment for prostate cancer Intensity Modulated Radiation